Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
Subjects will be randomly assigned to one of 3 treatment groups and receive 325 mg (65 mg elemental iron) iron supplements twice daily.
Uterine Fibroids|Anemia
DRUG: Proellex 25 mg|DRUG: Proellex 50 mg|DRUG: Placebo
The Comparison Between the 50 mg ProellexÂ® Dose Level and Placebo in the Change in Hemoglobin From Baseline to 3 Months., 3 months
Eligible female subjects will be randomly assigned to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately six months, which is comprised of a 4 - 6 week screening period, a three-month drug treatment period, and a one-month follow-up period.